In the BioHarmony Drug Report Database
Tazobactam
Zosyn, Zerbaxa (tazobactam) is a small molecule pharmaceutical. Tazobactam was first approved as Zosyn on 1993-10-22. It has been approved in Europe to treat bacterial infections. Zosyn in galaxy containers’s patent is valid until 2023-04-14 (FDA).
Trade Name
|
Zerbaxa |
|---|---|
Common Name
|
tazobactam |
ChEMBL ID
|
CHEMBL404 |
Indication
|
bacterial infections |
Drug Class
|
Beta-lactamase inhibitors |
Image (chem structure or protein)